Historie om Ditmarskerkrigen aar femten hundrede og Ditmarskens erobring under Kong Frederik den Anden med en historisk udsigt over Ditmarskerfolkets vilkaar og skiebne i aeldre tider.

Bibliographical foot-notes.

A queen of tears, Caroline Matilda, queen of Denmark and Norway and princess of Great Britain and Ireland.

"List of authorities": v. 2. p. 327-329.

Original ancedotes of Frederick the Great, king of Prussia, and of his family, his court, his ministers, his academies, and his literary friends.

Mode of access: Internet.

Original anecdotes of Frederick the Great, King of Prussia, and of his family, his court, his ministers, his academies, and his literary friends; collected during a familiar intercourse of twenty years with that prince.

Mode of access: Internet.

Posthumous works of Frederic II, King of Prussia.

"Translated from the French by Thomas Holcroft."

Scandinavia and its confines, in which are the Kingdoms of Sweden, Denmark, and Norway, divided into their principall provinces viz. Under the crown of Sweden, those of Gothland, Sweden, Lapland, Finland, Ingria, and Livonia; Under the crown of Denmark, those of Jutland, Sleswick, Zealand, Fyonie, &c. In Denmark those of Agger, Dronthem, and Wardhous, in Norway /

1 kartta :, käsinvär. ;, 56,4 x 86,7 cm, lehti 62,5 x 91,5 cm

Statement of Prince Frederick of Schleswig Holstein Noer. The crown of Denmark disposed of by a religious minister through a fraudulent treaty /

Mode of access: Internet.

Frederick II et Louis XV, d'apres des documents nouveaux; 1742-1744.

I. La retraite de Prague. Mort de Fleury; Louis XV veut gouverner lui-même. Évacuation de la Bavière; bataille de Dettingue. appendice.--II. Mission de Voltaire à Berlin. Louis XV à l'armée. La maladie du roi. Appendice.

Travels in Sweden, Denmark, and Norway.

NUC pre-1956,

Frederick the Great, his court and times;

Copy imperfect: illus. wanting.

Itinerary of Denmark, Sweden, Norway & Russia.

Mode of access: Internet.

Narrative of an expedition to the east coast of Greenland : sent by order of the king of Denmark, in search of the lost colonies, under the command of Captn. W. A. Graah /

Mode of access: Internet.

Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine : randomized double-blind phase II evaluation of safety and immunogenicity

A randomized, double-blind, study was conducted to evaluate the safety, tolerability and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) co-administered with live attenuated yellow fever (YF) vaccine (YF-17D strain; Stamaril(®), Sanofi Pasteur) or administered successively. Participants (n = 108) were randomized to receive: YF followed by JE-CV 30 days later, JE followed by YF 30 days later, or the co-administration of JE and YF followed or preceded by placebo 30 days later or earlier. Placebo was used in a double-dummy fashion to ensure masking. Neutralizing antibody titers against JE-CV, YF-17D and selected wild-type JE virus strains was determined using a 50% serum-dilution plaque reduction neutralization test. Seroconversion was defined as the appearance of a neutralizing antibody titer above the assay cut-off post-immunization when not present pre-injection at day 0, or a least a four-fold rise in neutralizing antibody titer measured before the pre-injection day 0 and later post vaccination samples. There were no serious adverse events. Most adverse events (AEs) after JE vaccination were mild to moderate in intensity, and similar to those reported following YF vaccination. Seroconversion to JE-CV was 100% and 91% in the JE/YF and YF/JE sequential vaccination groups, respectively, compared with 96% in the co-administration group. All participants seroconverted to YF vaccine and retained neutralizing titers above the assay cut-off at month six. Neutralizing antibodies against JE vaccine were detected in 82-100% of participants at month six. These results suggest that both vaccines may be successfully co-administered simultaneously or 30 days apart.